immunotherapeutic - Robuta Search

https://www.mdpi.com/1999-4915/9/12/382 Immunotherapeutic Potential of Oncolytic H-1 Parvovirus: Hints of Glioblastoma Microenvironment... Glioblastoma, one of the most aggressive primary brain tumors, is characterized by highly immunosuppressive microenvironment. This contributes to glioblastoma... h 1 immunotherapeutic potential oncolytic parvovirus https://www.aacr.org/patients-caregivers/progress-against-cancer/revising-the-dosing-of-a-cancer-immunotherapeutic/ Revising the Dosing of a Cancer Immunotherapeutic | The AACR May 21, 2020 - The U.S. Food and Drug Administration has approved an alternative dosing schedule for the immune checkpoint inhibitor pembrolizumab. revising dosing cancer immunotherapeutic aacr https://pmc.ncbi.nlm.nih.gov/articles/PMC10631209/ Multimeric immunotherapeutic complexes activating natural killer cells towards HIV-1 cure - PMC Combination antiretroviral therapy (cART) has dramatically extended the life expectancy of people living with HIV-1 and improved their quality of life. There... natural killer cells https://www.aacr.org/patients-caregivers/progress-against-cancer/a-new-immunotherapeutic-for-patients-with-lymphoma/ A New Immunotherapeutic for Patients With Lymphoma | The AACR Feb 22, 2021 - The FDA approved a CAR T-cell therapy to treat certain patients with large B-cell lymphoma, the most common form of non-Hodgkin lymphoma. a new for patients immunotherapeutic lymphoma aacr https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1089179/full Frontiers | Development and validation of a mutation-based model to predict immunotherapeutic... Immunotherapy has become increasingly important in the perioperative period of non-small-cell lung cancer (NSCLC). In this study, we intended to develop a mu... a mutation https://www.rug.nl/news/2012/09/28_voskens?lang=en Immunotherapeutic strategies in patients with solid malignancies. Crossing the line between... Mar 13, 2020 - PhD ceremony: Ms. C.J. Voskens, 12.45 uur, Grote Vergaderzaal, Oude Boteringestraat 44, Groningen crossing the line immunotherapeutic strategies patients https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.798471/full Frontiers | Robust Prediction of Prognosis and Immunotherapeutic Response for Clear Cell Renal Cell... It is of great urgency to explore useful prognostic markers and develop robust prognostic model for patients with clear-cell renal cell carcinoma (ccRCC). Th... https://pmc.ncbi.nlm.nih.gov/articles/PMC6769557/ Conceptual Development of Immunotherapeutic Approaches to Gastrointestinal Cancer - PMC Gastrointestinal (GI) cancer is one of the common causes of cancer-related death worldwide. Chemotherapy and/or immunotherapy are the current treatments, but... gastrointestinal cancer conceptual development immunotherapeutic approaches https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1468397/full Frontiers | Editorial: Molecular mechanisms and immunotherapeutic targets in nanomedicine-based... In this special issue, we have focused on cancer therapy using nanomedicines to develop advanced diagnostic and therapeutic strategies. Researchers and clini... frontiers editorial molecular mechanisms immunotherapeutic https://elifesciences.org/articles/55415/figures Figures and data in Host sirtuin 2 as an immunotherapeutic target against tuberculosis | eLife The inhibition of host Sirtuin-2 by AGK2 restricts mycobacterial growth in vivo by modulation of host transcriptome leading to activation of protective immune... https://www.spandidos-publications.com/10.3892/ol.2026.15588?text=fulltext Unveiling the prognostic and immunotherapeutic role of Tregs in lung cancer using integrated... Oncology Letters is an international journal devoted to Experimental and Clinical Oncology. https://www.aacr.org/patients-caregivers/progress-against-cancer/immunotherapeutic-expanded-to-follicular-lymphoma-obinutuzumab-gazyva/ Use of Immunotherapeutic Expanded to Follicular Lymphoma | The AACR Feb 4, 2020 - The FDA expanded the use of an immunotherapy to treat certain patients with follicular lymphoma. Learn more about this approval. follicular lymphoma use immunotherapeutic expanded aacr https://www.sciencedaily.com/releases/2015/11/151118070809.htm Investigational immunotherapeutic increased bladder cancer survival | ScienceDaily Among patients with metastatic bladder cancer that had progressed after platinum-based chemotherapy, those who received an investigational, personalized... bladder cancer immunotherapeutic increased survival sciencedaily https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.994828/full Frontiers | Pan-cancer analysis identifies migrasome-related genes as a potential immunotherapeutic... Introduction: The migrasome is a newly discovered organelle that resembles extracellular vesicles in structure. However, the function of the migrasome in tum... pan cancer analysis https://www.preprints.org/manuscript/202405.0885 Novel Diagnostic and Immunotherapeutic Approaches for Wheat Allergy[v1] | Preprints.org Wheat, a component of the staple diet globally, is a common food allergen in children. The symptoms of wheat allergy (WA) range from skin rash to shortness of... wheat allergy novel diagnostic immunotherapeutic approaches https://elifesciences.org/articles/84280 Oxygen levels at the time of activation determine T cell persistence and immunotherapeutic efficacy... Oxygen levels at the time of T cell activation are major determinants of function, even when T cells are subsequently expanded in high levels of oxygen. https://www.spandidos-publications.com/10.3892/ol.2026.15588 Unveiling the prognostic and immunotherapeutic role of Tregs in lung cancer using integrated... Oncology Letters is an international journal devoted to Experimental and Clinical Oncology. https://www.mdpi.com/2072-6694/16/20/3443 Immunotherapeutic Potential of Mutated NPM1 for the Treatment of Acute Myeloid Leukemia Acute myeloid leukemia (AML) is a malignant disease of the blood and bone marrow that is characterized by uncontrolled clonal proliferation of abnormal myeloid... for the immunotherapeutic potential mutated npm1 https://www.aacr.org/patients-caregivers/progress-against-cancer/an-immunotherapeutic-shows-promise-for-multiple-myeloma-patients-ineligible-for-pivotal-trial/ An Immunotherapeutic Shows Promise for Multiple Myeloma Patients Ineligible for Pivotal Trial |... Study found teclistamab-cqyv, an immunotherapy, led to responses in patients with high-risk, heavily pretreated multiple myeloma, including after prior BCMA... multiple myeloma immunotherapeutic shows promise https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1064616/full Frontiers | Serum cytokine levels and other associated factors as possible immunotherapeutic... Lung cancer is one of the most prevalent cancer types and the leading cause of cancer-related deaths worldwide. Non-small cell lung cancer (NSCLC) accounts f... and other frontiers serum cytokine levels https://www.prnewswire.co.uk/news-releases/psioxus-therapeutics-licenses-immunotherapeutic-delivery-technology-polymap-to-avidea-technologies-601235186.html PsiOxus Therapeutics Licenses Immunotherapeutic Delivery Technology 'Polymap' to Avidea Technologies /PRNewswire/ -- Avidea Technologies Inc. ("Avidea"), a biotechnology company, and PsiOxus Therapeutics Ltd. ("PsiOxus"), the immuno-oncology company, today... therapeutics licenses immunotherapeutic delivery technology https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.1001506/full Frontiers | Implications of m6A-associated snRNAs in the prognosis and immunotherapeutic responses... Abstract Background: Hepatocellular carcinoma (HCC) is the most prevalent pathological type of liver cancer worldwide with high mortality and poor prognosis....